Propanc Biopharma, Inc. SEC filings PPCB
Propanc Biopharma, Inc. has 438 filings in SEC EDGAR's recent list, going back to Jun 23, 2011. Its latest annual report, Form 10-K, was filed on Sep 25, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (listing notice). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice
|
Oct 29, 2026 | Oct 23, 2026 |
| DEF 14C | Information statement | Oct 21, 2026 | Oct 20, 2026 |
| PRE 14C | Filing | Oct 8, 2026 | Oct 8, 2026 |
| S-1 | Registration statement | Oct 5, 2026 | — |
| 10-K | Annual report | Sep 25, 2026 | Jun 30, 2026 |
| DEF 14C | Information statement | Aug 21, 2026 | Aug 20, 2026 |
| PRE 14C | Filing | Aug 5, 2026 | Aug 4, 2026 |
| EFFECT | Filing | Jul 27, 2026 | — |
| S-1 | Registration statement | Jul 17, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jul 14, 2026 | Jul 8, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| EFFECT | Filing | Apr 20, 2026 | — |
| CORRESP | Letter to the SEC | Apr 16, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 15, 2026 | — |
| S-1 | Registration statement | Apr 10, 2026 | — |
| DEF 14C | Information statement | Mar 31, 2026 | Mar 31, 2026 |
| PRE 14C | Filing | Mar 20, 2026 | Mar 19, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 19, 2026 | Mar 19, 2026 |
| 424B3 | Prospectus | Mar 6, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Feb 26, 2026 | Feb 20, 2026 |
| EFFECT | Filing | Feb 24, 2026 | — |
| CORRESP | Letter to the SEC | Feb 20, 2026 | — |
| S-1/A | Amended registration statement | Feb 19, 2026 | — |
| 10-Q | Quarterly report | Feb 17, 2026 | Dec 31, 2025 |
| CORRESP | Letter to the SEC | Feb 12, 2026 | — |
| CORRESP | Letter to the SEC | Feb 10, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2026 | — |
| S-1 | Registration statement | Feb 2, 2026 | — |
| 424B3 | Prospectus | Jan 30, 2026 | — |
| EFFECT | Filing | Jan 9, 2026 | — |
| 8-K |
Current report
Listing notice
|
Jan 7, 2026 | Dec 31, 2025 |
| CORRESP | Letter to the SEC | Jan 6, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2026 | — |
| S-1 | Registration statement | Dec 30, 2025 | — |
| DEF 14C | Information statement | Dec 29, 2025 | Dec 29, 2025 |
| PRE 14C | Filing | Dec 10, 2025 | Dec 10, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change
|
Nov 10, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Material agreement
|
Oct 14, 2025 | Oct 7, 2025 |
| 10-K | Annual report | Sep 29, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Aug 19, 2025 | Aug 14, 2025 |
| 424B3 | Prospectus | Aug 18, 2025 | — |
| 424B4 | Prospectus | Aug 18, 2025 | — |
| CERT | Filing | Aug 14, 2025 | — |
| EFFECT | Filing | Aug 13, 2025 | — |
| 8-A12B | Filing | Aug 13, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Aug 13, 2025 | Jul 31, 2025 |
| CORRESP | Letter to the SEC | Aug 12, 2025 | — |
| CORRESP | Letter to the SEC | Aug 12, 2025 | — |
| CORRESP | Letter to the SEC | Jul 31, 2025 | — |
| CORRESP | Letter to the SEC | Jul 31, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 30, 2025 | Jul 25, 2025 |
| CORRESP | Letter to the SEC | Jul 29, 2025 | — |
| CORRESP | Letter to the SEC | Jul 29, 2025 | — |
| S-1/A | Amended registration statement | Jul 28, 2025 | — |
| CORRESP | Letter to the SEC | Jul 24, 2025 | — |
| CORRESP | Letter to the SEC | Jul 24, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 22, 2025 | Jul 18, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 27, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 18, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 2, 2025 | May 7, 2025 |
| S-1/A | Amended registration statement | May 30, 2025 | — |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
May 8, 2025 | May 7, 2025 |
| S-1/A | Amended registration statement | Apr 25, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 21, 2025 | Mar 31, 2025 |
| S-1/A | Amended registration statement | Apr 8, 2025 | — |
| S-1/A | Amended registration statement | Apr 2, 2025 | — |
| S-1/A | Amended registration statement | Mar 31, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 18, 2025 | Mar 14, 2025 |
| 10-Q | Quarterly report | Feb 14, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Feb 12, 2025 | Feb 6, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 20, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 6, 2024 | Dec 3, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| UPLOAD | Letter from the SEC | Nov 6, 2024 | — |
| S-1 | Registration statement | Oct 30, 2024 | — |
| 10-K | Annual report | Sep 30, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 27, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 30, 2024 | Aug 26, 2024 |
| DEF 14C | Information statement | Aug 22, 2024 | Aug 22, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 15, 2024 | Aug 9, 2024 |
| PRE 14C | Filing | Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 7, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 2, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 21, 2024 | Jun 17, 2024 |
| 8-K/A |
Amended current report
Material agreement, New debt, Unregistered share sale
|
Jun 13, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 12, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 5, 2024 | May 31, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
May 16, 2024 | May 10, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 22, 2024 | Apr 16, 2024 |
| 8-K |
Current report
Other events
|
Apr 10, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 11, 2024 | Mar 5, 2024 |
| 10-Q | Quarterly report | Feb 20, 2024 | Dec 31, 2023 |
| NT 10-Q | Filing | Feb 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 15, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 7, 2023 | Dec 4, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| D | Filing | Nov 3, 2023 | — |
| 8-K |
Current report
Other events
|
Oct 30, 2023 | Oct 29, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 26, 2023 | Oct 26, 2023 |
| D | Filing | Oct 26, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 17, 2023 | Oct 16, 2023 |
| 424B4 | Prospectus | Oct 17, 2023 | — |
| EFFECT | Filing | Oct 12, 2023 | — |
| CORRESP | Letter to the SEC | Oct 10, 2023 | — |
| S-1/A | Amended registration statement | Oct 10, 2023 | — |
| S-1/A | Amended registration statement | Oct 6, 2023 | — |
| 10-K | Annual report | Sep 28, 2023 | Jun 30, 2023 |
| D | Filing | Aug 31, 2023 | — |
| D | Filing | Aug 31, 2023 | — |
| D | Filing | Aug 30, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 29, 2023 | Aug 29, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 21, 2023 | Aug 21, 2023 |
| D | Filing | Aug 16, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2023 | — |
| D | Filing | Aug 15, 2023 | — |
| S-1 | Registration statement | Aug 11, 2023 | — |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 26, 2023 | Jul 26, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 12, 2023 | Jun 29, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
May 5, 2023 | May 5, 2023 |
| 424B3 | Prospectus | Apr 4, 2023 | — |
| EFFECT | Filing | Mar 27, 2023 | — |
| POS AM | Filing | Mar 24, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 17, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Other events
|
Feb 22, 2023 | Feb 15, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Feb 21, 2023 | Feb 14, 2023 |
| 10-Q | Quarterly report | Feb 10, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 1, 2022 | Oct 26, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 12, 2022 | Oct 6, 2022 |
| DEF 14C | Information statement | Oct 5, 2022 | Oct 5, 2022 |
| 10-K | Annual report | Sep 28, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 27, 2022 | Sep 21, 2022 |
| PRE 14C | Filing | Sep 23, 2022 | Sep 23, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 18, 2022 | Aug 12, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jul 11, 2022 | Jul 6, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 7, 2022 | Jun 30, 2022 |
| DEF 14C | Information statement | Jun 9, 2022 | Jun 9, 2022 |
| PRE 14C | Filing | May 27, 2022 | May 27, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
May 18, 2022 | May 12, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 18, 2022 | Apr 12, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 1, 2022 | Mar 29, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 10, 2022 | Mar 7, 2022 |
| 424B3 | Prospectus | Feb 22, 2022 | — |
| 10-Q | Quarterly report | Feb 14, 2022 | Dec 31, 2021 |
| EFFECT | Filing | Feb 11, 2022 | — |
| CORRESP | Letter to the SEC | Feb 10, 2022 | — |
| S-1/A | Amended registration statement | Feb 10, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2022 | — |
| S-1 | Registration statement | Feb 3, 2022 | — |
| EFFECT | Filing | Jan 14, 2022 | — |
| POS AM | Filing | Jan 10, 2022 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 10, 2022 | Jan 4, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 13, 2021 | Dec 7, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 7, 2021 | Nov 30, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 1, 2021 | Nov 26, 2021 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 27, 2021 | Oct 21, 2021 |
| 10-K | Annual report | Sep 28, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 28, 2021 | Sep 22, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 25, 2021 | Aug 19, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Aug 18, 2021 | Aug 12, 2021 |
| 10-Q | Quarterly report | May 14, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 19, 2021 | Mar 16, 2021 |
| 10-Q | Quarterly report | Feb 12, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 11, 2021 | Jan 5, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 30, 2020 | Dec 23, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 16, 2020 | Dec 10, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 7, 2020 | Dec 2, 2020 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Nov 19, 2020 | Nov 17, 2020 |
| 10-Q | Quarterly report | Nov 16, 2020 | Sep 30, 2020 |
| EFFECT | Filing | Nov 12, 2020 | — |
| CORRESP | Letter to the SEC | Nov 10, 2020 | — |
| CORRESP | Letter to the SEC | Nov 3, 2020 | — |
| S-1/A | Amended registration statement | Nov 3, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2020 | — |
| S-1/A | Amended registration statement | Oct 14, 2020 | — |
| 10-K | Annual report | Oct 1, 2020 | Jun 30, 2020 |
| NT 10-K | Filing | Sep 29, 2020 | Jun 30, 2020 |
| S-1/A | Amended registration statement | Aug 13, 2020 | — |
| CORRESP | Letter to the SEC | Aug 13, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 6, 2020 | — |
| DEF 14C | Information statement | Aug 5, 2020 | Aug 5, 2020 |
| UPLOAD | Letter from the SEC | Jul 30, 2020 | — |
| CORRESP | Letter to the SEC | Jul 22, 2020 | — |
| PRER14C | Filing | Jul 22, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2020 | — |
| S-1/A | Amended registration statement | Jul 17, 2020 | — |
| CORRESP | Letter to the SEC | Jul 16, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 13, 2020 | — |
| PRER14C | Filing | Jul 2, 2020 | — |
| CORRESP | Letter to the SEC | Jul 2, 2020 | — |
| CORRESP | Letter to the SEC | Jun 26, 2020 | — |
| S-1/A | Amended registration statement | Jun 26, 2020 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PPCB (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Camberwell, Victoria, Australia
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1517681
- Former names
- Propanc Health Group Corp (until Apr 5, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.